SEARCH

SEARCH BY CITATION

References

  • 1
    Starzl TE, Klintmalm GB, Porter KA, Iwatsuki S, Schroter GP. Liver transplantation with use of cyclosporine A and prednisone. N Engl J Med 1981; 305:266269. MEDLINE
  • 2
    Iwatsuki S, Starzl TE, Todo S, Gordon RD, Esquivel CO, Tzakis AG, et al. Experience in 1,000 liver transplants under cyclosporine-steroid therapy: A survival report. Transplant Proc 1988; 20:498504. MEDLINE
  • 3
    Lowes JR, Hubscher SG, Neuberger JM. Chronic rejection of the liver allograft. Gastroenterol Clin North Am 1993; 22:401420. MEDLINE
  • 4
    Hubscher SG, Buckels JA, Elias E, McMaster P, Neuberger J. Vanishing bile-duct syndrome following liver transplantation—Is it reversible? Transplantation 1991; 51:10041010. MEDLINE
  • 5
    Hayry P, Isoniemi H, Yilmaz S, Mennander A, Lemstrom K, Raisanen-Sokolowski A. Chronic allograft rejection. Immunol Rev 1993; 134:3381. MEDLINE
  • 6
    Platz KP, Tullius SG, Mueller AR, Schumacher G, Nussler N, Neuhaus R, et al. Incidence and outcome of chronic rejection in CyA- and FK506-treated patients. Transplant Proc 1996; 28:31833184. MEDLINE
  • 7
    van Hoek B, Wiesner RH, Ludwig J, Gores GJ, Moore B, Krom RA. Combination immunosuppression with azathioprine reduces the incidence of ductopenic rejection and vanishing bile duct syndrome after liver transplantation. Transplant Proc 1991; 23:14031405. MEDLINE
  • 8
    Anonymous. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group. Lancet 1994; 344:423428. MEDLINE
  • 9
    Anonymous. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. The US Multicenter FK506 Liver Study Group. N Engl J Med 1994; 331:11101115. MEDLINE
  • 10
    Fung JJ, Eliasziw M, Todo S, Jain A, Demetris AJ, McMichael JP, et al. The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. J Am Coll Surg 1996; 183:117125. MEDLINE
  • 11
    Starzl TE, Donner A, Eliasziw M, Stitt L, Meier P, Fung JJ, et al. Randomised trialomania? The multicentre liver transplant trials of tacrolimus. Lancet 1995; 346:13461350. MEDLINE
  • 12
    Jain ABR, Kashyap R, Dodson F, Demetris AJ. Long-term survival after liver transplantation in 4000 consecutive patients at a single center. Ann Surg 2000; 232:490500. MEDLINE
  • 13
    Fung JJ, Todo S, Jain A, McCauley J, Alessiani M, Scotti C, et al. Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc 1990; 22:612. MEDLINE
  • 14
    Fung JJ, Todo S, Tzakis A, Demetris A, Jain A, Abu-Elmaged K, et al. Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: Benefits and pitfalls. Transplant Proc 1991; 23:1421. MEDLINE
  • 15
    Sher LS, Cosenza CA, Michel J, Makowka L, Miller CM, Schwartz ME, et al. Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: A report of the US Multicenter Liver Study Group. Transplantation 1997; 64:258263. MEDLINE
  • 16
    Demetris AJ, Fung JJ, Todo S, McCauley J, Jain A, Takaya S, et al. FK 506 used as rescue therapy for human liver allograft recipients. Transplant Proc 1991; 23:30053006. MEDLINE
  • 17
    Demetris AJ, Fung JJ, Todo S, McCauley J, Jain A, Takaya S, et al. Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy—A clinicopathologic study of 96 patients. Transplantation 1992; 53:10561062. MEDLINE
  • 18
    Blakolmer KJ, Ruppert A, Gray K, Duquesnoy E, Murase R. Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression. Transplantation 2000; 69:23302336. MEDLINE
  • 19
    Jain AB, Todo S, Fung JJ, Venkataramnan R, Day R, Bryant J, et al. Correlation of rejection episodes with FK 506 dosage, FK 506 level, and steroids following primary orthotopic liver transplant. Transplant Proc 1991; 23:30233025. MEDLINE
  • 20
    Jain AB, Fung JJ, Todo S, Alessiani M, Takaya S, Abu-Elmag DK, et al. Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. Transplant Proc 1991; 23:928930. MEDLINE
  • 21
    Jain AB, Fung JJ, Todo S, Reyes J, Selby R, Irish W, et al. One thousand consecutive primary orthotopic liver transplants under FK 506: Survival and adverse events. Transplant Proc 1995; 27:10991104. MEDLINE
  • 22
    Todo S, Fung JJ, Demetris AJ, Jain A, Venkataramanan R, Starzl TE. Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc 1990; 22:1316. MEDLINE
  • 23
    Todo S, Fung JJ, Starzl TE, Tzakis A, Demetris AJ, Kormos R, et al. Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg 1990; 212:295305. MEDLINE
  • 24
    Demetris AJ, Seaberg EC, Batts KP, Ferrell L, Lee RG, Markin R, et al. Chronic liver allograft rejection: A National Institute of Diabetes and Digestive and Kidney Diseases interinstitutional study analyzing the reliability of current criteria and proposal of an expanded definition. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Am J Surg Pathol 1998; 22:2839. MEDLINE
  • 25
    Demetris A, Adams D, Bellamy C, Blakolmer K, Clouston A, Dhillon AP, et al. Update of the International Banff Schema for Liver Allograft Rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology 2000; 31:792799. MEDLINE
  • 26
    Wiesner RH, Batts KP, Krom RA. Evolving concepts in the diagnosis, pathogenesis, and treatment of chronic hepatic allograft rejection. Liver Transpl Surg 1999; 5:388400. MEDLINE
  • 27
    Adams DH, Neuberger JM. Patterns of graft rejection following liver transplantation. J Hepatol 1990; 10:113119. MEDLINE
  • 28
    Milkiewicz P, Gunson B, Saksena S, Hathway M, Hubscher SG, Elias E. Increased incidence of chronic rejection in adult patients transplanted for autoimmune hepatitis: Assessment of risk factors. Transplantation 2000; 70:477480. MEDLINE
  • 29
    Bronsther O, Manez R, Kusne S, Irish W, Roland W, Jain A, et al. Posttransplant B, non-A non-B, and cytomegalovirus hepatitis increase the risk of developing chronic rejection after liver transplantation. Transplant Proc 1995; 27:12061207. MEDLINE
  • 30
    Manez R, White LT, Kusne S, Martin M, Demetris AJ, Starzl TE, et al. Association between donor-recipient HLA-DR compatibility and cytomegalovirus hepatitis and chronic rejection in liver transplantation. Transplant Proc 1993; 25:908909. MEDLINE
  • 31
    Manez R, White LT, Linden P, Kusne S, Martin M. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation. Transplantation 1993; 55:10671071. MEDLINE
  • 32
    O'Reilly PM, Rosen HR, Shackleton CR, McDiarmid S, Holt C, Busuttil RW, et al. Causes of graft loss following liver transplantation for chronic hepatitis C. Transplant Proc 1997; 29:526528. MEDLINE
  • 33
    O'Grady JG, Alexander GJ, Sutherland S, Donaldson PT, Harvey F, Portmann B, et al. Cytomegalovirus infection and donor/recipient HLA antigens: Interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation. Lancet 1988; 2:302305. MEDLINE
  • 34
    McGory RW, Ishitani MB, Oliveira WM, Stevenson WC, McCullough CS, Dickson RC, et al. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 1996; 61:13581364. MEDLINE
  • 35
    Lauchart W, Muller R, Pichlmayr R. Long-term immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts. Transplant Proc 1987; 19:40514053. MEDLINE
  • 36
    Demetris AJ, Markus BH, Esquivel C, Van Thiel DH, Saidman S, Gordon R. Pathologic analysis of liver transplantation for primary biliary cirrhosis. Hepatology 1988; 8:939947. MEDLINE
  • 37
    Candinas D, Gunson BK, Nightingale P, Hubscher S, McMaster P, Neuberger JM. Sex mismatch as a risk factor for chronic rejection of liver allografts. Lancet 1995; 346:11171121. MEDLINE
  • 38
    Milkiewicz P, Hubscher SG, Skiba G, Hathaway M, Elias E. Recurrence of autoimmune hepatitis after liver transplantation. Transplantation 1999; 68:253256. MEDLINE
  • 39
    Hubscher SG, Elias E, Buckels JA, Mayer AD, McMaster P, Neuberger JM. Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation. J Hepatol 1993; 18:173184. MEDLINE
  • 40
    Jeyarajah DR, Netto GJ, Lee SP, Testa G, Abbasoglu O, Husberg BS, et al. Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: Is chronic rejection part of the disease process? Transplantation 1998; 66:13001306. MEDLINE
  • 41
    Graziadei IW, Wiesner RH, Batts KP, Marotta PJ, LaRusso NF, Porayko MK, et al. Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology 1999; 29:10501056. MEDLINE
  • 42
    Jain AM, Kashyap R, Green M, Gronsky C, Starzl T, Fung J, Reyes J. Comparative long term evaluation of tacrolimus and cyclosporin in pediatric liver transplantation. Transplantation 2000; 70:617625. MEDLINE
  • 43
    Molmenti E, Mazariegos G, Bueno J, Cacciarelli T, Alasio T, Khanna A, et al. Noncompliance after pediatric liver transplantation. Transplant Proc 1999; 31:408. MEDLINE
  • 44
    Rovelli M, Palmeri D, Vossler E, Bartus S, Hull D, Schweizer R. Noncompliance in organ transplant recipients. Transplant Proc 1989; 21:833834. MEDLINE
  • 45
    Hayashi M, Keeffe EB, Krams SM, Martinez OM, Ojogho ON, So SKS, et al. Allograft rejection after liver transplantation for autoimmune liver diseases. Liver Transpl Surg 1998; 4:208214. MEDLINE
  • 46
    Kemnitz J, Gubernatis G, Bunzendahl H, Ringe B, Pichlmayr R, Georgii A. Criteria for the histopathological classification of liver allograft rejection and their clinical relevance. Transplant Proc 1989; 21:22082210. MEDLINE
  • 47
    Kemnitz J, Ringe B, Cohnert TR, Gubernatis G, Choritz H, Georgii A. Bile duct injury as a part of diagnostic criteria for liver allograft rejection. Hum Pathol 1989; 20:132143. MEDLINE
  • 48
    De Carlis L, Sansalone CV, Rondinara GF, Colella G, Slim AO, Rossetti O, et al. Is the use of marginal donors justified in liver transplantation? Analysis of results and proposal of modern criteria. Transpl Int 1996; 9(suppl 1):S414S417. MEDLINE
  • 49
    Marino IR, Doyle HR, Aldrighetti L, Doria C, McMichael J, Gayowski T, et al. Effect of donor age and sex on the outcome of liver transplantation. Hepatology 1995; 22:17541762. MEDLINE
  • 50
    Blakolmer K, Jain A, Ruppert K, Gray E, Duquesnoy R, Murase N, et al. Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: Long-term follow-up and evaluation of features for histopathological staging. Transplantation 2000; 69:23302336. MEDLINE
  • 51
    Donaldson PT, Alexander GJ, O'Grady J, Neuberger J, Portmann B, Thick M, et al. Evidence for an immune response to HLA class I antigens in the vanishing-bile duct syndrome after liver transplantation. Lancet 1987; 1:945951. MEDLINE
  • 52
    Donaldson P, Underhill J, Doherty D, Hayllar K, Calne R, Tan KC. Influence of human leukocyte antigen matching on liver allograft survival and rejection: “The dualistic effect.” Hepatology 1993; 17:10081015. MEDLINE
  • 53
    Wiesner RH, Demetris AJ, Belle SH, Seaberg EC, Lake JR, Zetterman RK, et al. Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome. Hepatology 1998; 28:638645. MEDLINE
  • 54
    Batts KP, Moore SB, Perkins JD, Wiesner RH, Grambsch PM, Krom RA. Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allografts. Transplantation 1988; 45:376379. MEDLINE
  • 55
    Donaldson PT, Thomson LJ, Heads A, Underhill JA, Vaughan RW, Rolando N, et al. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry. Transplantation 1995; 60:10161023. MEDLINE